 | Eiger BioPharmaceuticals, Inc. | |||
| NGM : EIGR || Location: United States | ||||
$3.95-0.05 (-1.25%) |
0.03 M | 2.96 - 4.0 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 15, 2024 | 0.034 M |
| Feb. 29, 2024 | 0.041 M |
| Feb. 15, 2024 | 0.042 M |
| Jan. 31, 2024 | 0.033 M |
| Jan. 12, 2024 | 0.029 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -9.90 | -12.30 | -24.19% |
| 06/30/2023 | -12.55 | -14.10 | -12.39% |
| 03/31/2023 | -14.47 | -15.60 | -7.78% |
| 12/31/2022 | -16.63 | -17.10 | -2.80% |
| 09/30/2022 | -0.53 | -0.62 | -16.59% |
EIGR Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 1.479M | Shares Float | 1.272M |
| Short Float | 0.034M | Market Cap | 0.00M |
| Institution ownership | 43.86% | Insider ownership | 11.799% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -58.50 | Forward EPS | -3.60 |